1-7 of 7
John Smyth
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

TNF-α antagonism inhibits the inflammatory cytokine gene expression and NF-κ B activity in the tumour microenvironment in patients with ovarian cancer

Kellie Charles, Susan Hoare, Thorsten Hagemann, Dianne Scott, Rhona Aird, Uma Prabhakar, Vora Renu, Katherine Li, Marian Nakada, Mark DeWitte, Robert Corringham, John Smyth, Frances Balkwill
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 5068.
Published: 01 May 2007
View articletitled, TNF-α antagonism inhibits the inflammatory cytokine gene expression and NF-κ B activity in the tumour microenvironment in patients with ovarian cancer
Journal Articles

Infliximab, a humanised anti-TNF-a monoclonal antibody, exhibits biological activity in the ovarian tumor microenvironment in patients

Kellie A. Charles, Susan A. Hoare, Thorsten Hagemann, Diane Scott, Rhona Aird, John Smyth, Fran R. Balkwill
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1055–1056.
Published: 15 April 2006
View articletitled, Infliximab, a humanised anti-TNF-a monoclonal antibody, exhibits biological activity in the ovarian tumor microenvironment in patients
Journal Articles

Modified estrogen-receptor transcription complex assembly in resistant human breast cancer cell lines

Catherine Naughton, Barbara Kuske, Kenneth Macleod, William Miller, John Smyth, Robert Clarke, David Cameron, Simon Langdon
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 297–298.
Published: 01 May 2005
View articletitled, Modified estrogen-receptor transcription complex assembly in resistant human breast cancer cell lines
Journal Articles

Identification of indicators of Pertuzumab (rhuMAb 2C4) activity in ovarian cancer models

Simon P. Langdon, Peter Mullen, Max Hasmann, David Cameron, John Smyth
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1196.
Published: 01 May 2005
View articletitled, Identification of indicators of Pertuzumab (rhuMAb 2C4) activity in ovarian cancer models
Journal Articles

Collateral resistance to both estrogen and erbB receptor activated growth in endocrine resistant MCF-7 breast cancer cell lines

Kate Moore, Barbara Kuske, Kenneth Macleod, Robert Clarke, John Smyth, Simon Langdon, David Cameron
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 296.
Published: 01 May 2005
View articletitled, Collateral resistance to both estrogen and erbB receptor activated growth in endocrine resistant MCF-7 breast cancer cell lines
Journal Articles

Broad Spectrum Neuropeptide Antagonists Inhibit the Growth of Small Cell Lung Cancer in Vivo

Simon Langdon, Tariq Sethi, Alison Ritchie, Morwenna Muir, John Smyth, Enrique Rozengurt
Journal: Cancer Research
Cancer Res (1992) 52 (16): 4554–4557.
Published: 01 August 1992
View articletitled, Broad Spectrum Neuropeptide Antagonists Inhibit the Growth of Small Cell Lung Cancer in Vivo
Open the PDF for Broad Spectrum Neuropeptide Antagonists Inhibit the Growth of Small Cell Lung Cancer in Vivo in another window
Journal Articles

Growth of Small Cell Lung Cancer Cells: Stimulation by Multiple Neuropeptides and Inhibition by Broad Spectrum Antagonists in Vitro and in Vivo

Tariq Sethi, Simon Langdon, John Smyth, Enrique Rozengurt
Journal: Cancer Research
Cancer Res (1992) 52 (9_Supplement): 2737s–2742s.
Published: 01 May 1992
View articletitled, Growth of Small Cell Lung Cancer Cells: Stimulation by Multiple Neuropeptides and Inhibition by Broad Spectrum Antagonists in Vitro and in Vivo
Open the PDF for Growth of Small Cell Lung Cancer Cells: Stimulation by Multiple Neuropeptides and Inhibition by Broad Spectrum Antagonists in Vitro and in Vivo in another window